(Q53200551)

12 May 2018

title

Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. (English)

1 reference

12 May 2018

0 references

Lannfelt L

1

1 reference

12 May 2018

Basun H

2

1 reference

12 May 2018

Wahlund LO

3

1 reference

12 May 2018

Rowe BA

4

1 reference

12 May 2018

Wagner SL

5

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 August 1995

1 reference

12 May 2018

number of pages

4

1 reference

inferred from page(s)

published in

Nature Medicine

1 reference

12 May 2018

volume

1

1 reference

12 May 2018

page(s)

829-832

1 reference

12 May 2018

issue

8

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1038/nm0895-829

exact match

0 references

cites work

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. A clinical and genealogical investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation.

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type share a decrease in cerebrospinal fluid levels of amyloid beta-protein precursor

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Altered cleavage and secretion of a recombinant beta-APP bearing the Swedish familial Alzheimer's disease mutation

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family.

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Low frequency of the APP 670/671 mutation in familial Alzheimer's disease in Sweden

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Decreased levels of soluble amyloid beta-protein precursor are associated with Alzheimer's disease in concordant and discordant monozygous twin pairs.

1 reference

https://api.crossref.org/works/10.1038%2FNM0895-829

7 January 2021

Identifiers

DOI

10.1038/NM0895-829

1 reference

12 May 2018

release_dxbhntb5pffhbhlokvy2jkwpiy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dxbhntb5pffhbhlokvy2jkwpiy

24 November 2022

mapped directly with Wikidata item

PubMed ID

7585189

1 reference

12 May 2018